Friday , September 17 2021

Bharat Biotech starts Covaxin’s at-risk manufacturing; expanding capacity

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.Read MoreCompanies

About

Check Also

Social impact venture Charitnation helps more than 25000 families of migrant and daily wage earners during Covid-19 crisis in India

New Delhi [India], September 15 (ANI/SRV Media): India was put in lockdown to halt the …

Leave a Reply

Your email address will not be published. Required fields are marked *